Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!
Oxygen Biotherapeutics, Inc., (“OBI”) (NASDAQ: OXBT) a developer of oxygen-carrying therapeutics, today announced results for the fiscal year (FY) ended April 30, 2013.
Financial Highlights:
•Government grant revenue increased 263% year-over-year to $1.14 million due to progress of the underlying studies for FDA-required preclinical trials on Oxycyte® and the achievement of contractual milestones under the grant
Help employers find you! Check out all the jobs and post your resume.
